$18.70
-0.14-0.74%
At close: Aug 6, 5:00 PM EST
$17.50
-1.20-6.42%
After Hours: 9:28 AM EST
Avalo Therapeutics Inc
AVTXNASDAQ
Avalo Therapeutics Earnings & Forecasts
Avalo Therapeutics (AVTX) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Avalo Therapeutics Guidance
Recent Earnings Results
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.63 | $-1.01 | $-1.51 | $-1.65 |
| Actual | $-0.83 | $-0.98 | $-0.48 | $-2.19 |
| Surprise | -31.8% | +2.97% | +68.2% | -32.7% |
| Revenue | ||||
| Estimate | — | — | — | — |
| Actual | $0 | $0 | $59000 | $0 |
| Surprise | — | — | — | — |
Analyst Estimates — Forward PeriodsSource: Wall Street consensus
| Metric | Q3 '26E | Q4 '26E | Q1 '27E |
|---|---|---|---|
| Earnings Per Share (Non-GAAP) | |||
| Consensus | $-0.57 | $-0.58 | $-0.61 |
| Revenue | |||
| Consensus | — | — | — |
